Publications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (37)

2024

  1. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study

    Hepatology, Vol. 80, Núm. 5, pp. 1196-1211

  2. Demographic Trends in Liver Transplant Survivors after 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy

    Transplantation Direct, Vol. 10, Núm. 8, pp. e1684

  3. Hepatic hemodynamic study: More than just HVPG measurement

    Gastroenterologia y Hepatologia

  4. Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

    Hepatology

  5. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

    Journal of Hepatology, Vol. 81, Núm. 1, pp. 76-83

2023

  1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

2022

  1. Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    The American journal of gastroenterology, Vol. 117, Núm. 5, pp. 818

  2. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

    European Journal of Neurology, Vol. 29, Núm. 2, pp. 400-412

  3. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history

    United European Gastroenterology Journal, Vol. 10, Núm. 8, pp. 805-816

  4. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    American Journal of Gastroenterology, Vol. 117, Núm. 2, pp. 301-310

2021

  1. HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

    Transplant International, Vol. 34, Núm. 11, pp. 2214-2225

  2. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

    Journal of Hepatology, Vol. 75, Núm. 5, pp. 1026-1033

  3. Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients

    Therapeutic Advances in Gastroenterology, Vol. 14

2020

  1. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

    Hepatology, Vol. 72, Núm. 6, pp. 1924-1934

2019

  1. Advances in health and disease: Paracentesis in medicine

    Advances in Health and Disease (Nova Science Publishers, Inc.), pp. 1-52

  2. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients

    Liver Transplantation, Vol. 25, Núm. 8, pp. 1177-1186

  3. Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

    PLoS ONE, Vol. 14, Núm. 11

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2017

  1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

  2. Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

    Journal of Viral Hepatitis, Vol. 24, Núm. 4, pp. 304-311